Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-κB Inhibition and Gene Expression Signature-Reference-Cited by-同舟云学术

Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-κB Inhibition and Gene Expression Signature

Published:2006-02-23 Issue:5 Volume:69 Page:1615-1623
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Olivier Sabine,Close Pierre,Castermans Emilie,de Leval Laurence,Tabruyn Sebastien,Chariot Alain,Malaise Michel,Merville Marie-Paule,Bours Vincent,Franchimont Nathalie

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Multiple Myeloma

2. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

3. Constitutive nuclear factor–κB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins

4. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene

5. NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach;Molecular Biotechnology;2022-12-12

2. Raloxifene impedes cisplatin-induced nephrotoxicity through inhibition of Proinflammatory cytokines in female wistar rats;PAK J PHARM SCI;2021

3. Raloxifene Protects Cisplatin-Induced Renal Injury in Mice via Inhibiting Oxidative Stress;OncoTargets and Therapy;2021-09

4. A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options;Current Medicinal Chemistry;2020-11-11

5. Inflammation, NF-κB, and Chronic Diseases: How are They Linked?;Critical Reviews in Immunology;2020